According to the latest financial report of AnaptysBio, the latest earnings per share (TTM) for the company is -1.14. Investing in companies with strong earnings per share can potentially provide higher returns.
Interested in knowing about AnaptysBio's free cash flow? The latest report shows it as -10.13M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of AnaptysBio shows that the company's current ratio is 10.23, indicating healthy liquidity.
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of AnaptysBio, the quick ratio is 10.08, indicating that the company can meet its short-term debt obligations.
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of AnaptysBio, the total asset return on investment (ROA) is -7.14%.
Gross margin can provide insight into a company's pricing strategy and cost structure. Check AnaptysBio's latest financial report to see how their gross margin is doing - currently at --.
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of AnaptysBio, the net profit margin is -109.44%, which is a good sign for its profitability.